{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"20"}],"units":"Participants"}],"description":"Elevated blood calcium levels (total blood calcium level \\> 10.5 mg/dL or 2.6 mmol/L) with/without elevated parathyroid hormone (PTH) (serum intact PTH \\> 65 pg/ml or 6.9 pmol/L) at first postoperative visit. Participants will be categorized as having persistent hyperparathyroidism or hypercalcemia (transient) Yes or No.","groups":[{"description":"For participants assigned to the study arm, the surgeon will use the PTeye as an intraoperative tool to identify if a suspect tissue is a parathyroid or not, during the parathyroid surgery.","id":"OG000","title":"Parathyroid Eye (PTeye)"},{"description":"The surgeon will proceed with the parathyroid surgery as usual, while relying solely on her/his surgical experience in identifying the parathyroid glands during the operations.","id":"OG001","title":"Usual Standard of Care"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Participants from both groups were missing labs. Not all PTEye participants returned to the clinic for blood draws within 5-14 days to obtain lab values required to calculate this endpoint and standard clinical care does not necessitate participants returning for labs routinely at each follow-up time points.","reportingStatus":"POSTED","timeFrame":"5-14 days after PTx procedure","title":"Number of Participants With Persistent Hyperparathyroidism or Hypercalcemia (Transient)","type":"SECONDARY","unitOfMeasure":"Participants"}